| Literature DB >> 28058059 |
Xia Shen1, Zhenyu Zhao1, Xuan Luo1, Hao Wang1, Benxiang Hu1, Zihu Guo2.
Abstract
Background. Mental disorder is a group of systemic diseases characterized by a variety of physical and mental discomfort, which has become the rising threat to human life. Herbal medicines were used to treat mental disorders for thousand years in China in which the molecular mechanism is not yet clear. Objective. To systematically explain the mechanisms of SiNiSan (SNS) formula on the treatment of mental disorders. Method. A systems pharmacology method, with ADME screening, targets prediction, and DAVID enrichment analysis, was employed as the principal approach in our study. Results. 60 active ingredients of SNS formula and 187 mental disorders related targets were discovered to have interactions with them. Furthermore, the enrichment analysis of drug-target network showed that SNS probably acts through "multi-ingredient, multitarget, and multisystems" holistic coordination in different organs pattern by indirectly regulating the nutritional and metabolic pathway even their serial complications. Conclusions. Our research provides a reference for the molecular mechanism of medicinal herbs in the treatment of mental disease on a systematic level. Hopefully, it will also provide a theoretical basis for the discovery of lead compounds of natural medicines for other diseases based on traditional medicine.Entities:
Year: 2016 PMID: 28058059 PMCID: PMC5183803 DOI: 10.1155/2016/9146378
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Compound-Target network of SNS formula. The blue and purple nodes represent the compounds from SNS formula. The purple nodes represent the compounds which can pass the BBB and the blue nodes with nonpenetrating compounds. The nodes colored with yellow (brain, node = 78), green (liver, node = 22), and red (both brain and liver, node = 14), respectively, represent the targets from different organs. The red line represents the interaction between BBB penetrating compounds and targets from the brain.
Figure 2Target-Disease network of 116 potential targets and 170 related diseases which are classified into 15 groups by MeSH. Blue circle, purple rectangles, and green node represent the potential targets, related diseases, and the MeSH classification of diseases. And green triangles belong to nervous diseases.
Figure 3The statistical information of potential diseases from different six main MeSH classifications discovered by database.
High correlation diseases with potential targets of SNS formula.
| Disease name | Related targets (gene) symbol | MeSH class | Degree |
|---|---|---|---|
| Autistic disorder | APC, PRF1, HTR1D, CHRNA7, OXTR, DRD3, DHCR7, XDH, AR, CHRNA4, HTR3A, HTR2A, HTR2C, IGFBP3, KCNMA1, MAOB | Mental disorder | 18 |
| Schizophrenia | CHRNA7, CYP2D6, NOS1, BCHE, HRH1, HTR2A, HTR3A, NR3C1, OXTR, DRD3, GSK3B, MC4R, HTR2C, KCNMA1, MAOB, GRIN2B, CYP1A2 | Mental disorder | 18 |
| Epilepsy | UGT2B7, GRIN2B, SV2A, CYP1A1, ABCG2, CHRM2, CYP2C9, CYP2A6, HRH1, OPRM1, ADRA2A, CHRNA4, BDKRB1, CHRNA7, CYP2D6, BCHE | Nervous system diseases | 17 |
| Peripheral nervous system diseases | ALOX12, PARP2, CYP1A2, SLC10A2, TLR4, CCL5, UGT2B7, TRPC4, ESR1, SRD5A2, SRD5A1, ELOVL6, CES1, ABCC1, CYP24A1, POLB | Nervous system diseases | 17 |
| Obesity | MLNR, MCHR1, CES1, STS, PTPN1, BCHE, HTR2C, ACACB, MC4R, MMP9, ESRRA, CCK, HTR2A, ESR1, KCNMA1 | Nutritional and metabolic diseases | 16 |
| Pain | HRH1, BDKRB1, OPRK1, CHRNA4, CHRNA7, GRIN2B, F2R, OPRM1, CHRM4, P2RX3, CNR2, CHRM2 | Nervous system diseases | 13 |
| Seizures | OPRM1, CHRNA7, CHRNA4, DRD3, CCK, CYP1A1, HCN1, NOS1, SIGMAR1, BCHE, OPRK1 | Nervous system diseases | 12 |
| Atherosclerosis | TLR4, HRH1, F3, ESR1, ALOX5, NR1H2, CNR2, LTA4H, CES1, PLA2G2A, MMP9 | Vascular diseases | 12 |
| Hypertension | HTR2B, NR3C1, HSD11B2, CYP3A4, CYP1A1, ADCY5, ABCC1, ADRA2A, AR, ATP1A1, EDNRA | Vascular diseases | 12 |
| Diabetes mellitus, type 2 | PYGM, GAA, CYP2C9, TNFRSF1A, EDNRB, CYP1A2, PTPN1, EDNRA, KCNQ1, ADCY5 | Nutritional and metabolic diseases | 12 |
| Hyperalgesia | ALOX12, P2RX3, OPRM1, CNR2, ALOX5, NOS1, DRD3, HTR2A, BDKRB1, GRIN2B | Nervous system diseases | 11 |
| Alzheimer disease | HTR2A, ESR1, GSK3B, BCHE, CYP2D6, CALM1, MAPT, CHRNA7, APP | Nervous system diseases | 10 |
| Heart failure | NR3C2, XDH, NOX4, GSK3B, ATP2A1, ADRA2A, ATP1A1, TNFRSF1A, HTR2B | Heart diseases | 10 |
| Myocardial infarction | ABCG2, GSK3B, CYP1A2, LTA4H, CYP2C9, NR3C2, HSD11B2, ESR1, MMP9 | Heart diseases | 10 |